Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-Inflammatory Effects of Lastacaft in Allergic Conjunctivitis
NCT02308501Phase 4Completed
- Start
- Dec 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of alcaftadine in allergic conjunctivitis (AC). Started Dec 2014; status: completed.
02
Drugs
alcaftadine
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT02308501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02308501.